S M K Alam1,2, S Jasti1, S K Kshirsagar3, D S Tannetta4, R A Dragovic4, C W Redman4, I L Sargent4, H C Hodes5, T L Nauser5, T Fortes6,7, A M Filler6,7, K Behan7, D R Martin6, T A Fields8, B K Petroff3,9, M G Petroff1,3,10. 1. 1 Department of Anatomy and Cell Biology, University of Kansas Medical Center, Kansas City, KS, USA. 2. 2 Department of Biochemistry and Molecular Biology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh. 3. 3 Department of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, MI, USA. 4. 4 Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Oxford, UK. 5. 5 Center for Women's Health, Overland Park, KS, USA. 6. 6 Sparrow Hospital, Lansing, MI, USA. 7. 7 College of Human Medicine, Michigan State University, East Lansing, MI, USA. 8. 8 Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA. 9. 9 Veterinary Diagnostic Laboratory, Michigan State University, East Lansing, MI, USA. 10. 10 Microbiology and Molecular Genetics, Michigan State University, East Lansing, MI, USA.
Abstract
BACKGROUND: Many parallels exist between growth and development of the placenta and that of cancer. One parallel is shared expression of antigens that may have functional importance and may be recognized by the immune system. Here, we characterize expression and regulation of one such antigen, Trophoblast glycoprotein (TPGB; also called 5T4), in the placenta across gestation, in placentas of preeclamptic (PE) pregnancies, and in purified microvesicles and exosomes. METHODS: Trophoblast glycoprotein expression was analyzed by real-time reverse transcription-polymerase chain reaction (RT-PCR), Western blot, and immunohistochemistry. Regulation of 5T4 in cytotrophoblast cells was examined under either differentiating conditions of epidermal growth factor or under varying oxygen conditions. Microvesicles and exosomes were purified from supernatant of cultured and perfused placentas. RESULTS: Trophoblast glycoprotein expression was prominent at the microvillus surface of syncytiotrophoblast and on the extravillous trophoblast cells, with minimal expression in undifferentiated cytotrophoblasts and normal tissues. Trophoblast glycoprotein expression was elevated in malignant tumors. In cytotrophoblasts, 5T4 was induced by in vitro differentiation, and its messenger RNA (mRNA) was increased under conditions of low oxygen. PE placentas expressed higher 5T4 mRNA than matched control placentas. Trophoblast glycoprotein was prominent within shed placental microvesicles and exosomes. CONCLUSION: Given the potential functional and known immunological importance of 5T4 in cancer, these studies reveal a class of proteins that may influence placental development and/or sensitize the maternal immune system. In extravillous trophoblasts, 5T4 may function in epithelial-to-mesenchymal transition during placentation. The role of syncytiotrophoblast 5T4 is unknown, but its abundance in shed syncytial vesicles may signify route of sensitization of the maternal immune system.
BACKGROUND: Many parallels exist between growth and development of the placenta and that of cancer. One parallel is shared expression of antigens that may have functional importance and may be recognized by the immune system. Here, we characterize expression and regulation of one such antigen, Trophoblast glycoprotein (TPGB; also called 5T4), in the placenta across gestation, in placentas of preeclamptic (PE) pregnancies, and in purified microvesicles and exosomes. METHODS:Trophoblast glycoprotein expression was analyzed by real-time reverse transcription-polymerase chain reaction (RT-PCR), Western blot, and immunohistochemistry. Regulation of 5T4 in cytotrophoblast cells was examined under either differentiating conditions of epidermal growth factor or under varying oxygen conditions. Microvesicles and exosomes were purified from supernatant of cultured and perfused placentas. RESULTS:Trophoblast glycoprotein expression was prominent at the microvillus surface of syncytiotrophoblast and on the extravillous trophoblast cells, with minimal expression in undifferentiated cytotrophoblasts and normal tissues. Trophoblast glycoprotein expression was elevated in malignant tumors. In cytotrophoblasts, 5T4 was induced by in vitro differentiation, and its messenger RNA (mRNA) was increased under conditions of low oxygen. PE placentas expressed higher 5T4 mRNA than matched control placentas. Trophoblast glycoprotein was prominent within shed placental microvesicles and exosomes. CONCLUSION: Given the potential functional and known immunological importance of 5T4 in cancer, these studies reveal a class of proteins that may influence placental development and/or sensitize the maternal immune system. In extravillous trophoblasts, 5T4 may function in epithelial-to-mesenchymal transition during placentation. The role of syncytiotrophoblast 5T4 is unknown, but its abundance in shed syncytial vesicles may signify route of sensitization of the maternal immune system.
Authors: J Wolfers; A Lozier; G Raposo; A Regnault; C Théry; C Masurier; C Flament; S Pouzieux; F Faure; T Tursz; E Angevin; S Amigorena; L Zitvogel Journal: Nat Med Date: 2001-03 Impact factor: 53.440
Authors: Abida Awan; Melinda R Lucic; David M Shaw; Freda Sheppard; Caroline Westwater; Steve A Lyons; Peter L Stern Journal: Biochem Biophys Res Commun Date: 2002-01-25 Impact factor: 3.575
Authors: Lindsey N Block; Brittany D Bowman; Jenna Kropp Schmidt; Logan T Keding; Aleksandar K Stanic; Thaddeus G Golos Journal: Biol Reprod Date: 2021-01-04 Impact factor: 4.161
Authors: Sara K Taylor; Sahar Houshdaran; Joshua F Robinson; Matthew J Gormley; Elaine Y Kwan; Mirhan Kapidzic; Birgit Schilling; Linda C Giudice; Susan J Fisher Journal: Development Date: 2020-09-08 Impact factor: 6.862
Authors: Wittaya Chaiwangyen; José M Murrieta-Coxca; Rodolfo R Favaro; Stella M Photini; Ruby N Gutiérrez-Samudio; Ekkehard Schleussner; Udo R Markert; Diana M Morales-Prieto Journal: Int J Mol Sci Date: 2020-05-14 Impact factor: 5.923